Flagship explainer
What drives Silence Therapeutics plc’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$88.6M | FY2025 |
| |
| Income before tax | −$88.6M | FY2025 |
|
| Operating income | −$91.1M | FY2025 |
|
| $559000 | FY2025 |
| |
| Ending assets | $131M | FY2025 |
|
| Beginning assets | $203M | FY2024 |
|
| $62.3M | FY2025 |
| |
| $134M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-092591